Kamran Alam, CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc. (TSHA), sold 102,817 shares at $4.75 ($485K) on 2026-01-23, disclosed to the SEC on 2026-01-27.
Open-market sale of $485k TSHA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 78,968 | $375K | 77.3% |
| 2 | $4.61 | 23,849 | $110K | 22.7% |
| Total | $4.72 avg | 102,817 | $485K | 100% |
| Filing → |
| TSHA | SELL | 2023-08-25 | $77K | — | Filing → |
| TSHA | SELL | 2022-08-24 | $12K | — | Filing → |
| TSHA | SELL | 2022-08-22 | $106K | — | Filing → |